 |
MorphoSys AG
MOR
|
1.02 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Aligos Therapeutics
ALGS
|
2.53 |
$ 8.97 |
2.87 % |
$ 88.7 M |
USA |
 |
Alterity Therapeutics Limited
ATHE
|
7.02 |
$ 3.66 |
- |
$ 8.81 B |
Australia |
 |
Allakos
ALLK
|
3.26 |
- |
- |
$ 28.6 M |
USA |
 |
Aptinyx
APTX
|
2.35 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Aravive
ARAV
|
1.21 |
- |
-13.39 % |
$ 1.45 M |
USA |
 |
Anavex Life Sciences Corp.
AVXL
|
11.6 |
$ 3.21 |
3.05 % |
$ 274 M |
USA |
 |
I-Mab
IMAB
|
8.96 |
- |
- |
$ 866 M |
China |
 |
AlloVir
ALVR
|
2.84 |
- |
4.14 % |
$ 49.1 M |
USA |
 |
Applied Molecular Transport
AMTI
|
2.31 |
- |
- |
$ 10.1 M |
USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
0.922 |
- |
2.54 % |
$ 160 B |
France |
 |
Biophytis SA
BPTS
|
1.34 |
- |
-13.47 % |
$ 169 M |
France |
 |
Brainstorm Cell Therapeutics
BCLI
|
0.0929 |
- |
-2.5 % |
$ 5.88 M |
USA |
 |
Applied Therapeutics
APLT
|
0.762 |
- |
- |
$ 8.42 M |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
BeiGene, Ltd.
BGNE
|
2.14 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
bluebird bio
BLUE
|
1.46 |
- |
- |
$ 546 M |
USA |
 |
BioNTech SE
BNTX
|
7.95 |
$ 95.59 |
-1.15 % |
$ 27.2 B |
Germany |
 |
Midatech Pharma plc
MTP
|
2.68 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Burford Capital Limited
BUR
|
2.14 |
$ 4.68 |
4.23 % |
$ 746 M |
Britain |
 |
Cabaletta Bio
CABA
|
3.11 |
$ 3.27 |
2.19 % |
$ 329 M |
USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.94 |
$ 21.46 |
0.47 % |
$ 1 B |
USA |
 |
Checkpoint Therapeutics
CKPT
|
0.372 |
- |
- |
$ 169 M |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
1.04 |
- |
- |
- |
Russia |
 |
Adverum Biotechnologies
ADVM
|
1.65 |
- |
- |
$ 86.2 M |
USA |
 |
Advaxis
ADXS
|
5.93 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Clearside Biomedical
CLSD
|
0.681 |
- |
- |
$ 25.3 M |
USA |
 |
Aeterna Zentaris
AEZS
|
1.22 |
- |
5.93 % |
$ 314 M |
Canada |
 |
AgeX Therapeutics
AGE
|
0.995 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
12.4 |
- |
- |
$ 1.01 B |
USA |
 |
Akebia Therapeutics
AKBA
|
1.09 |
$ 1.49 |
1.35 % |
$ 383 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.79 |
- |
- |
$ 26.5 M |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.76 |
$ 3.03 |
3.77 % |
$ 4.99 M |
Israel |
 |
Aquestive Therapeutics
AQST
|
0.827 |
$ 4.19 |
- |
$ 448 M |
USA |
 |
Arcutis Biotherapeutics
ARQT
|
1.78 |
$ 24.98 |
3.55 % |
$ 3.18 B |
USA |
 |
Chimerix
CMRX
|
10.8 |
- |
- |
$ 756 M |
USA |
 |
Concert Pharmaceuticals
CNCE
|
3.11 |
- |
- |
$ 401 M |
USA |
 |
AIkido Pharma
AIKI
|
2.59 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Celldex Therapeutics
CLDX
|
10.4 |
$ 32.74 |
0.46 % |
$ 2.17 B |
USA |
 |
Autolus Therapeutics plc
AUTL
|
1.43 |
$ 1.48 |
0.46 % |
$ 394 M |
Britain |
 |
Aptose Biosciences
APTO
|
0.269 |
- |
-45.71 % |
$ 1.2 M |
Canada |
 |
Cidara Therapeutics
CDTX
|
4.17 |
- |
- |
$ 1.41 B |
USA |
 |
AVROBIO
AVRO
|
15.9 |
- |
1083.1 % |
$ 745 M |
USA |
 |
CNS Pharmaceuticals
CNSP
|
2.1 |
$ 2.44 |
-2.99 % |
$ 1.08 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
6.43 |
- |
- |
$ 7.46 M |
Israel |
 |
AstraZeneca PLC
AZN
|
1.75 |
- |
- |
$ 96.9 B |
Britain |
 |
Akero Therapeutics
AKRO
|
10.9 |
- |
- |
$ 3.67 B |
USA |
 |
CTI BioPharma Corp.
CTIC
|
0.878 |
- |
- |
$ 1.2 B |
USA |
 |
CureVac N.V.
CVAC
|
2.47 |
- |
- |
$ 867 M |
Germany |